{"id":586299,"date":"2022-02-14T06:06:02","date_gmt":"2022-02-14T06:06:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=586299"},"modified":"2022-02-14T06:06:02","modified_gmt":"2022-02-14T06:06:02","slug":"vivaceutical-launches-pan-india-pcd-pharma-franchise-program","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/vivaceutical-launches-pan-india-pcd-pharma-franchise-program_586299.html","title":{"rendered":"Vivaceutical Launches Pan India PCD Pharma Franchise Program"},"content":{"rendered":"

Panchkula – 14th February, 2022 –<\/strong> Vivaceutical<\/a> joins the Indian Pharmaceutical Industry with exciting services and it’s most awaited PCD Pharma Franchise Program. The newly established pharma company based in Panchkula, Haryana opens up new opportunities for individuals, businesses and pharmaceutical stakeholders at a national scale to set foot in the pharma market. <\/p>\n

Vivaceutical has long been in the works and has finally revealed its services and programs to the public. But above all, it’s their PCD Pharma Franchise Program that’s catching the eye of the public. <\/p>\n

The Panchkula based pharma company deals with a wide range of pharma segments and products that include gynae pharma products, oncology drugs, pharmaceuticals for medical conditions related to female and male hormones, obesity, hair loss\/growth and more. With the help of their well-designed franchise program, medical representatives, pharmaceutical distributors, pharmacy dealers and others can begin distributing medications and profit with the partnership.<\/p>\n

When asked about the decision of choosing the PCD Pharma Franchise<\/a> model, Mr. Raman Sharma, Founder, comments:<\/p>\n

“In order to grow within the pharma sector and expand the business in a successful way, we believe that the PCD Pharma Franchise Model is the best one. This model also aligns with our vision to make quality and affordable medications more accessible. By partnering with doctors, pharmacies and others, we bring superior medications to the public and hope to improve the standard of healthcare in the country. Additionally, it lets us help people build a foundation and profit from the booming pharma industry.”  <\/p>\n

In addition to this, Vivaceutical<\/strong> also brings third party manufacturing services to the table. The company took extra efforts to offer nothing less than WHO-GMP certified manufacturing facilities. It’s an opportunity for innovative individuals to access the means to manufacture quality pharmaceuticals. <\/p>\n

Vivaceutical<\/strong> is helmed by a team of skilled professionals aware of the need to deliver benchmark pharmaceuticals in the medical sector. It matches all the standards of top PCD Pharma Companies<\/a> and is all ready to take a seat with the top names in the country. <\/p>\n

About Vivaceutical<\/strong><\/p>\n

Established in Panchkula, Haryana, Vivaceuticals is a PCD Pharma company offering their expertise and industry leadership to people looking to establish roots in the pharma industry. They render services in the form of pan India pharma franchises and third party manufacturing services. <\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Vivaceutical Pvt Ltd<\/a>
Contact Person:<\/strong> Aman Gill
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +919785701313
City:<\/strong> Panchkulla
State:<\/strong> Haryana
Country:<\/strong> India
Website:<\/strong> vivaceutical.com<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Panchkula – 14th February, 2022 – Vivaceutical joins the Indian Pharmaceutical Industry with exciting services and it’s most awaited PCD Pharma Franchise Program. The newly established pharma company based in Panchkula, Haryana opens up new opportunities for individuals, businesses and … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,412,406,422],"tags":[],"class_list":["post-586299","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-News-Current-Affairs","category-Pharmaceuticals-Biotech","category-Retail"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/586299","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=586299"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/586299\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=586299"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=586299"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=586299"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}